The move towards statutory regulation of herbal practitioners originates from the House of Lords Select Committee on Science and Technology's Report on Complementary and Alternative Medicine (HMSO 2000) and the Government Response (Department of Health 2001) to it. The report recognised that complementary and alternative medicine (CAM) are both widespread and increasing across the developed world and that this has implications for patient safety. The Committee identified that there was considerable diversity of standards amongst the professions and that, for some therapies, the public was at risk from practitioners with inadequate or inappropriate training.
Herbal medicine was identified as posing particular challenges for public health. The statutory regulation of herbal medicine practitioners was supported because the profession meets agreed criteria that makes this appropriate. These criteria are risk to the public through poor practice, a voluntary regulatory system and a credible evidence base. Regulation would ensure that appropriate training was established. This would result in competent practitioners with an understanding of the evidence base for their therapy along with an appreciation of the limitations of the treatments they can provide. Safe practitioners would understand when to refer. Effective regulation would therefore seek to safeguard the public from incompetent practitioners. It would identify practitioners suitably qualified to use a range of potent herbal remedies that are not appropriate for over-the counter sale.
The House of Lords Select Committee on Science and Technology's Report on Complementary and Alternative Medicine (HMSO 2000) stated that CAM included a large range of therapies and that while some had well-developed regulatory structures, others were fragmented with no consensus about regulation. The evidence base for the various CAM therapies was also variable but the majority did not have one. It proposed that CAM therapies should be classified within 3 groups. Therapies assigned to Group 1 included the most organised CAM professions where NHS provision is increasing and where research into their effectiveness had either already commenced or was likely to be beneficial. The therapies assigned to Group 2 also have support from the NHS but are used in a complementary way alongside conventional medicine. Again they require further research and need to develop their regulatory structures. Those therapies assigned to Group 3 were considered to have no evidence base for clinical effectiveness.
Herbal medicine, or phytotherapy, was defined as, "a system of medicine which uses various remedies derived from plants and plant extracts to treat disorders and maintain good health". It was assigned to Group 1 along with acupuncture, chiropractic, homeopathy and osteopathy. Other therapies that also use herbal products, and in some cases acupuncture, in their practice were assigned to Groups 2 and 3. These include Maharishi Ayurvedic Medicine (Group 2), Ayurvedic Medicine (Group 3), Chinese Herbal Medicine (Group 3) and Traditional Chinese Medicine (Group 3). The proposals within this document take account of all traditions using herbal medicine as part of their practice in line with the Government's response to the House of Lords report.
The Government Response (Department of Health 2001) to the report from the House of Lords recommended that herbal medicine and acupuncture should work towards statutory regulation under the Health Act 1999 and that this was both in the interests of practitioners and patients. Taking account of the public health risks, statutory regulation should be implemented as soon as practicable.
In January 2002, the Department of Health, together with the Prince of Wales's Foundation for Integrated Health and the EHTPA established the Herbal Medicine Regulatory Working Group. The remit for the Group was to make recommendations on the regulation of herbal medicine practitioners and on the reform of S12(1) of Medicines Act 1968. In 2003, the HMRWG published its report Recommendations on the Regulation of Herbal Practitioners in the UK.
The HMRWG report includes a parallel report on the regulation of herbal remedies made up to meet individual needs and supplied to the public after a personal consultation under the provisions of Section 12(1) of the Medicines Act 1968. Proposals in this latter report aim to ensure that the herbal remedies supplied by practitioners are of the necessary quality to ensure public confidence in herbal treatment. In its response to the House of Lords Report, the Government agreed that future regulatory arrangements relating to the ingredients and products used by individual herbal practitioners should safeguard quality and safety standards while recognising the diversity of practice. The Government indicated an intention to hold discussions with herbal interest groups on this issue to consider the way forward and said that in the light of this they would consider whether any changes in legislation would be required in order to reach a satisfactory regulatory position. In effect, the work of the HMRWG on the issue of possible reforms to the regime of unlicensed herbal remedies supplied under Section 12(1) of the Medicines Act 1968 represents the first stage in the process of exploration and dialogue envisaged by the Government. It needs to be seen as distinct from, but complementary to, the wider European negotiations on the proposed Directive on Traditional Herbal Medicinal Products which relates to industrially produced traditional herbal remedies sold over-the-counter direct to the public.
Working in parallel to the HMRWG was the Acupuncture Regulatory Working Group which was set up to make recommendations on the regulation of acupuncturists. The ARWG published its report The Statutory Regulation of the Acupuncture Profession in September 2003.
The HMRWG, unlike the ARWG, concluded that the two professions should be regulated together, thereby addressing the high practitioner costs of running small regulatory bodies and resolving the need for Traditional Chinese Medicine practitioners, who practise both herbal medicine and acupuncture, to be registered twice and pay two sets of fees.
The Department of Health ran a consultation on the regulation of the two professions published as The Regulation of Herbal Medicine and Acupuncture: Proposals for Statutory Regulation in March 2004. The results of this consultation were published by the DH in February 2005 as Statutory Regulation of Herbal Medicine and Acupuncture: Report on the Consultation.
The MHRA ran a simulataneous consultation on S12.1 reform MLX299: Proposals for the Reform of the Regulation of Unlicensed Herbal Remedies in the United Kingdom made up to meet the Needs of Individual Patients and published the results in January 2005 as Summary of responses to consultation document MLX299.
Delays at the Department of Health due to the General Election in 2005 and pending developments in healthcare regulation as part of the Foster Review stalled further work for nearly a year. In early 2006, the Government set up the Steering Group for the regulation of Acupuncture, Herbal Medicine and Traditional Chinese Medicine to consider how to progress the regulation of these professions.
On the 12th June 2008 'The Steering Group Report for the regulation of acupuncture, herbal medicine and traditional Chinese medicine' was presented to the DH Minister Ben Bradshaw.
On the 16th June 2008 The Steering Group, chaired by Professor Pittilo, held a press conference at the Kings Fund to inform on this document.
Response to DOH Joint Consultation on the Report to Ministers from the DH Steering Group on the Statutory Regulation of Acupuncture, Herbal Medicine, Traditional Chinese Medicine and Other Traditional Medicine Systems Practised in the UK - click here to view (pdf).
In 2011 the Secretary of State gave the go ahead for the statutory regulation of herbal practitioners. Since that time the Department of Health has not kept to the timetable outlined by the Minister and in 2014 the Undersecretary of State for Health Services, Dan Poulter, launched a new herbal working group to review legal questions about the provision of third party manufactured and/or supplied herbal medicines to herbal practitioners.
For more information on the regulation of complementary and alternative medicine (CAM) in the EU please click here to view (pdf).